<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23508">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02070913</url>
  </required_header>
  <id_info>
    <org_study_id>EDC-2191</org_study_id>
    <nct_id>NCT02070913</nct_id>
  </id_info>
  <brief_title>COOL-AMI EU Case Series Clinical Study</brief_title>
  <acronym>COOL-AMI EU</acronym>
  <official_title>COOL-AMI EU Case Series Clinical Study: A Single-Center Case Series Clinical Study to Assess the Feasibility of Integrating Therapeutic Hypothermia Using the ZOLL IVTM System as an Adjunctive Therapy to Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZOLL Circulation, Inc., USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ZOLL Circulation, Inc., USA</source>
  <oversight_info>
    <authority>Poland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center, prospective case series clinical study consecutively enrolling up to 10
      patients with expected duration of 12 months or less. The study objectives are to evaluate
      retention and the feasibility of integrating therapeutic hypothermia using the ZOLL IVTM
      System.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Time from hospital arrival to Percutaneous Coronary Intervention (PCI).</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from hospital arrival to initiation of cooling.</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of subjects achieving target temperature.</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of those enrolled that complete the study protocol.</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who present with clinical signs and symptoms of acute myocardial infarction and
        meet all Inclusion and Exclusion criteria will be considered for case study presentation
        in this clinical trial without regard to age, gender or ethnicity.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is 18 years of age.

          -  The patient must have symptoms consistent with AMI

          -  MI with ST-segment elevation

          -  The patient is eligible for PCI.

          -  The expected timing of the treatment pathway for the patient will allow for at least
             10 minutes of cooling with the IVTM System prior to PCI.

          -  The patient or patient legal representative is willing to provide written, informed
             consent to participate in this clinical study.

        Exclusion Criteria:

          -  The patient has had a previous myocardial infarction

          -  The patient is experiencing cardiogenic shock

          -  The patient is experiencing acute pulmonary edema.

          -  The patient is presenting with cardiac arrest.

          -  The patient is presenting with Killip risk stratification class II through IV.

          -  The patient is presenting with Atrial Fibrillation.

          -  The patient has a history of a prior large myocardial infarct or an infarct in the
             same segment that is currently affected.

          -  The patient requires an immediate surgical or procedural intervention other than PCI

          -  The patient has an aortic dissection.

          -  The patient has hepatic failure.

          -  The patient has end stage kidney disease.

          -  The patient is febrile

          -  Known chronic Congestive Heart Failure (CHF).

          -  Known previous CABG.

          -  Known recent stroke

          -  Cardio-pulmonary decompensation that has occurred en route to the hospital

          -  Contraindications to hypothermia

          -  The patient has a known hypersensitivity or contraindication to aspirin, heparin, or
             sensitivity to contrast media, which cannot be adequately pre-medicated.

          -  The patient has a known history of coagulopathy

          -  The patient is known to be pregnant

          -  The patient has a known hypersensitivity to antishivering medications.

          -  Patient has a known history of severe hepatic or renal impairment.

          -  The patient has an Inferior Vena Cava filter in place (IVC).

          -  The patient has a life expectancy of less than 1 year

          -  The patient has a known, unresolved history of drug use

          -  The patient is currently enrolled another investigational drug or device trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Renée Kochevar</last_name>
    <email>rkochevar@zoll.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik für allgemeine und interventionelle Kardiologie, Universitäres Herzzentrum</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Diemert, M.D</last_name>
    </contact>
    <investigator>
      <last_name>Patrick Diemert, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruppiner Kliniken GmbH</name>
      <address>
        <city>Neuruppin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirk Schmailzl, M.D</last_name>
      <phone>00493391391011</phone>
    </contact>
    <investigator>
      <last_name>Kirk Schmailzl, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, Dr. Jurasz University Hospital, Bydgoszcz</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacek Kubica, M.D, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jacek Kubica, M.D, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Invasive Cardiology Dept.,</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrzej Ochała, M.D, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Andrzej Ochała, M.D, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology,</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Witkowski, MD, PhD,FESC</last_name>
    </contact>
    <investigator>
      <last_name>Adam Witkowski, MD, PhD,FESC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Silesian Center for Heart Diseases, Zabrze</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beata Sredniawa, MD, PhD, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Beata Sredniawa, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University in Łódź, Bieganski Hospital</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Peruga, M.D, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jan Peruga, M.D, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Essex Cardiothoracic Centre, Anglia Ruskin University</name>
      <address>
        <city>Essex</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Davies</last_name>
      <phone>00447961424133</phone>
      <email>john.davies@btuh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Keeble, BSc,M.D,MCRP</last_name>
      <phone>00441268394673</phone>
      <email>thomaskeeble@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Keeble, BSc, M.D, MCRP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Davies</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiac Research Sister, King's College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafal Dworakowski, M.D</last_name>
      <phone>00442032994967</phone>
      <email>rdworakowski@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Rafal Dworakowski, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 20, 2014</lastchanged_date>
  <firstreceived_date>September 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypothermia</keyword>
  <keyword>Acute Myocardial Infarction</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>AMI</keyword>
  <keyword>PCI</keyword>
  <keyword>Therapeutic Hypothermia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
